Application 214735
- Type
- ANDA
- Sponsor
- GRANULES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214735-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214735-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A214735-001 | AA | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A214735-001 | AA | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A214735-001 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A214735-001 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A214735-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214735-001 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A214735-001 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214735-001 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214735-001 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214735-001 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214735-001 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214735-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214735-001 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214735-001 | AA | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214735-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9be0ad4e-3efa-1a24-e053-2995a90a60d5 | 2024-02-22 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | American Regent, Inc. | 62267afe-1a73-4623-984e-646db590ec5b | 2024-02-07 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | c4c3be3a-ea28-864f-e053-2a95a90a701a | 2024-01-30 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | e76bc0e4-68f5-70b4-e053-2a95a90a451e | 2024-01-22 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 579d2499-6520-41fb-ae52-f3d8b9af8950 | 2024-01-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | NorthStar RxLLC | ed22456b-b488-49ec-b96b-2541f5f3c955 | 2024-01-10 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | FH2 Pharma LLC | 18ca98ed-522d-470f-bb22-908bbd7d489a | 2023-12-31 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 0933e843-df2a-3d32-e063-6394a90a1037 | 2023-11-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE 1ML | GLYCOPYRROLATE | XIROMED LLC | 1bb2fa8a-3318-1e9a-2c79-8371bcae3d1c | 2023-10-23 | Warnings, Adverse reactions | GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 250eeef7-b1a9-45e7-a927-7807232e10be | 2023-09-22 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 54458620-d888-4df6-ae4b-78c3dfed3423 | 2023-08-16 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 88d3e865-8dca-4c89-b6f7-a34c481f75b9 | 2023-08-16 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 4c733750-45fe-4876-8e4f-c61c52470405 | 2023-06-06 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 86abf577-562c-5eb1-e053-2a91aa0ac10f | 2023-06-01 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 66726c2b-27e8-5dd1-e053-2991aa0a1ba7 | 2023-06-01 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 69353cc1-f5d4-170b-e053-2a91aa0ad5a5 | 2023-05-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 6934f467-949f-97cc-e053-2a91aa0a05fb | 2023-05-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 95fbe384-eaff-1f2e-e053-2a95a90a0313 | 2023-05-15 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f126596-7fbf-7a48-e053-2995a90abac7 | 2023-05-15 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f12016d-9033-00b4-e053-2a95a90ad02a | 2023-05-15 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.